Compare STTK & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STTK | TWIN |
|---|---|---|
| Founded | 2016 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.9M | 269.7M |
| IPO Year | 2020 | 1994 |
| Metric | STTK | TWIN |
|---|---|---|
| Price | $6.07 | $15.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $7.60 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 674.5K | 33.9K |
| Earning Date | 03-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | ★ 53.02 | N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | $1,000,000.00 | ★ $340,738,000.00 |
| Revenue This Year | N/A | $10.79 |
| Revenue Next Year | N/A | $8.43 |
| P/E Ratio | ★ N/A | $10.06 |
| Revenue Growth | N/A | ★ 15.45 |
| 52 Week Low | $0.69 | $6.16 |
| 52 Week High | $6.81 | $19.63 |
| Indicator | STTK | TWIN |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 42.69 |
| Support Level | $1.85 | $14.80 |
| Resistance Level | N/A | $16.62 |
| Average True Range (ATR) | 0.37 | 0.76 |
| MACD | -0.02 | 0.03 |
| Stochastic Oscillator | 40.42 | 36.11 |
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.